PLN 2.37
(-1.25%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 8.63 Million PLN | -55.04% |
2022 | 19.19 Million PLN | -5.43% |
2021 | 20.3 Million PLN | -32.41% |
2020 | 30.03 Million PLN | 13.88% |
2019 | 26.37 Million PLN | -2.44% |
2018 | 27.03 Million PLN | 19.6% |
2017 | 22.6 Million PLN | 16.21% |
2016 | 19.45 Million PLN | 236.38% |
2015 | 5.78 Million PLN | 387.1% |
2014 | 1.18 Million PLN | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 11.4 Million PLN | 22.0% |
2024 Q1 | 9.34 Million PLN | 8.25% |
2023 Q2 | 19.84 Million PLN | -8.76% |
2023 Q4 | 8.63 Million PLN | -56.14% |
2023 Q1 | 21.74 Million PLN | 13.26% |
2023 Q3 | 19.67 Million PLN | -0.82% |
2023 FY | 8.63 Million PLN | -55.04% |
2022 Q1 | 18.45 Million PLN | -9.08% |
2022 FY | 19.19 Million PLN | -5.43% |
2022 Q4 | 19.19 Million PLN | 16.55% |
2022 Q3 | 16.47 Million PLN | -6.8% |
2022 Q2 | 17.67 Million PLN | -4.24% |
2021 Q3 | 26.61 Million PLN | -3.35% |
2021 Q2 | 27.53 Million PLN | -3.81% |
2021 Q1 | 28.62 Million PLN | -4.69% |
2021 FY | 20.3 Million PLN | -32.41% |
2021 Q4 | 20.3 Million PLN | -23.72% |
2020 Q1 | 26.45 Million PLN | 0.29% |
2020 Q4 | 30.03 Million PLN | 12.99% |
2020 Q3 | 26.58 Million PLN | 1.59% |
2020 FY | 30.03 Million PLN | 13.88% |
2020 Q2 | 26.16 Million PLN | -1.07% |
2019 Q3 | 26.97 Million PLN | 0.86% |
2019 Q1 | 27.07 Million PLN | 0.15% |
2019 FY | 26.37 Million PLN | -2.44% |
2019 Q4 | 26.37 Million PLN | -2.21% |
2019 Q2 | 26.74 Million PLN | -1.23% |
2018 Q1 | 23.04 Million PLN | 1.93% |
2018 Q4 | 27.03 Million PLN | 21.62% |
2018 Q2 | 21.42 Million PLN | -7.04% |
2018 Q3 | 22.22 Million PLN | 3.77% |
2018 FY | 27.03 Million PLN | 19.6% |
2017 Q4 | 22.6 Million PLN | 34.06% |
2017 Q1 | - PLN | 0.0% |
2017 FY | 22.6 Million PLN | 16.21% |
2017 Q3 | 16.86 Million PLN | 0.0% |
2016 FY | 19.45 Million PLN | 236.38% |
2015 FY | 5.78 Million PLN | 387.1% |
2014 FY | 1.18 Million PLN | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Bioceltix S.A. | 12.73 Million PLN | 32.223% |
BIOTON S.A. | 822.22 Million PLN | 98.95% |
Captor Therapeutics Spolka Akcyjna | 97.29 Million PLN | 91.128% |
Mabion S.A. | 208.25 Million PLN | 95.855% |
Molecure S.A. | 168.57 Million PLN | 94.88% |
Pharmena S.A. | 24.13 Million PLN | 64.232% |
Poltreg S.A. | 127.09 Million PLN | 93.209% |
Pure Biologics Spólka Akcyjna | 22.73 Million PLN | 62.039% |
Ryvu Therapeutics S.A. | 403.2 Million PLN | 97.859% |
Synthaverse S.A. | 265.9 Million PLN | 96.754% |
Urteste S.A. | 29.59 Million PLN | 70.837% |